Granite Investment Partners, LLC Global Blood Therapeutics, Inc. Transaction History

Granite Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$25.48 - $37.34 $2.56 Million - $3.76 Million	-100,582 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$32.46 - $43.42 $26,811 - $35,864	826 Added 0.83%	100,582 $3.52 Million
Q1 2021 May 13, 2021	BUY	$38.94 - $50.85 $149,957 - $195,823	3,851 Added 4.02%	99,756 $4.07 Million
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $3.61 Million - $6.12 Million	95,905 New	95,905 $4.15 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.